reMYND NV
PrivateLast Round
Series B
Extension
Jan 22, 2021
Total Funding Raised
$28.18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
reMYND NV is a biotechnology company that develops disease-modifying treatments for neurodegenerative disorders such as Alzheimer's and Parkinson's disease, while also providing contract research services for preclinical drug testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
reMYND NV Comparables
Compare reMYND NV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biotrofix, Inc. | 79% | |
| InnoSer Nederland | 78% | |
| MD Biosciences | 77% |
reMYND NV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 22, 2021 | ||||
| Series B | Dec 18, 2018 |
reMYND NV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B Extension |
| Korys | Series B Extension, Series B |
| KU Leuven | Series B Extension, Series B |
| PMV | Series B Extension, Series B |
| BNP Paribas Fortis Private Equity | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 85% MoM.
- Feb 8, 2026
Grew 41% QoQ, from 22 to 31 employees.
reMYND NV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about reMYND NV's valuation, stock price, and market status.
Is reMYND NV a public or private company?
reMYND NV is a private company.
What is the current stock price of reMYND NV?
reMYND NV is a private company with no public stock price. No recent secondary market data is available.
How much is reMYND NV worth (valuation)?
Valuation information for reMYND NV is not publicly available.
Can I buy reMYND NV stock?
reMYND NV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was reMYND NV's last funding round?
reMYND NV's most recent funding round was Series B Extension on January 22, 2021.
Who are the main investors in reMYND NV?
Key investors in reMYND NV include Korys, PMV.
Will reMYND NV IPO soon?
No public IPO plans have been announced for reMYND NV.
How can I track reMYND NV secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor reMYND NV's secondary market activity and sign up for updates.